Skip to main content

Blackburn Course in Obesity Medicine: Obesity Medicine Board Review - 7.75 CME Credits

A comprehensive review by leading experts in preparation for ABOM certification

Start Date: December 5, 2017
Duration: ~ 8 hours
Price: $395

Course Description

The Blackburn Course in Obesity Medicine: Obesity Medicine Board Review is an intensive review designed to prepare potential diplomates for the American Board of Obesity Medicine (ABOM) certification examination. It is a comprehensive review of obesity medicine, targeted to physicians with a specialized interest in this discipline.

Course participants will hear authorities in medicine, surgery, pediatrics, nutrition, endocrinology, gastroenterology and psychology from the country’s leading obesity treatment and research centers speak on critical topics in the prevention and treatment of obesity and related disorders.

The topics covered are as follows:

  • Pathophysiology of Obesity: Hormonal, Neural, and Environmental Contributors
  • Nutritional Assessment and Therapy
  • Cardiorespiratory Fitness and Exercise
  • Pediatrics: Patient Assessment and Management
  • Surgical Treatment of Obesity
  • Pharmacological Treatment of Obesity
  • Behavioral Assessment and Therapy
  • Genetic and Syndromic Obesity
  • Obesity Comorbidities
  • Question and Answer Lightning Rounds

What You'll Learn

  • Consolidate knowledge of basic and clinical information within obesity medicine to comprehensively diagnose and treat patients
  • Optimize the opportunity to pass the American Board of Obesity Medicine (ABOM) subspecialty examination

Want to purchase this course for a group?

You can purchase enrollment codes for this course to distribute to your team

Purchase for a Group

Instructors

Nadia N. Ahmad, MD, MPH

Nadia N. Ahmad, MD, MPH Medical Director, Obesity Medicine Institute, Dubai, UA; Senior Advisor, Obesity Solutions, Johnson & Johnson Medical Devices—Middle East, Dubai, UAEE

W. Scott Butsch, MD, MS

W. Scott Butsch, MD, MS Instructor in Medicine, Harvard Medical School; Assistant in Medicine, Massachusetts General Hospital

Paul M. Copeland, MD, MPhil

Paul M. Copeland, MD, MPhil Assistant Professor of Medicine, Harvard Medical School; Physician, MGH Weight Center, Massachusetts General Hospital

Mark J. Gorman, PhD

Mark J. Gorman, PhD Instructor in Psychology, Harvard Medical School; Psychologist, MGH Weight Center, Massachusetts General Hospital

Sriram Machineni, MD

Sriram Machineni, MD Assistant Professor of Medicine, University of North Carolina School of Medicine

Gitanjali Srivastava, MD

Gitanjali Srivastava, MD Assistant Professor of Medicine, Boston University School of Medicine; Director, Obesity Medicine & Nutrition Fellowship, Department of Endocrinology, Boston Medical Center

COURSE OUTLINE

Blackburn Course in Obesity Medicine: Obesity Medicine Board Review is organized as follows:

Welcome to the Blackburn Course in Obesity Medicine
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Viewing Videos
Grading and Certificates

Board Review Session 1
Pathophysiology 1: Pathophysiology of Obesity
Nutrition Assessment and Therapy
Cardiorespiratory Fitness and Exercise

Board Review Session 2
Pathophysiology 2: Neural Control of Energy Balance
Pediatrics 1: Patient Assessment
Pediatrics 2: Patient Management
Lightning Round 1

Board Review Session 3
Pathophysiology 3: Environmental Modulators of Energy Balance
Bariatric Surgery
Pharmacotherapy
Behavioral Assessment and Therapy

Board Review Session 4
Genetic and Syndromic Obesity
Obesity Comorbidities
Lightning Round 2

CME Certificate
CME Posttest
Course Evaluation

ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS

ACCREDITATION STATEMENT

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT

The Harvard Medical School designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT

DISCLOSURE POLICY

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

DISCLOSURE STATEMENT

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Course Planners and Faculty:

Name: Caroline Apovian, MD
Relationship: Consultant
Companies: Arena, EnteroMedics, Gelesis, Johnson & Johnson, Merck, Novo Nordisk, Nutrisystem, Orexigen, Sanofi, Scientific Intake, Takeda, Zafgen

Relationship: Research Funding
Companies: Aspire Bariatrics, Dr. Robert C. & Veronica Atkins Foundation, GI Dynamics, Lilly, MetaProteomics, MYOS Corporation, Orexigen, Pfizer, Sanofi

Relationship: Stock Owner
Company: Science Smart LLC

Name: W. Scott Butsch, MD, MSc
Relationship: Consultant
Company: Merck

Name: Lee M. Kaplan, MD, PhD
Relationship: Scientific Advisor
Companies: Apollo Endosurgery, Astra Zeneca, Ethicon, Fractcyl, Gelesis, GI Dynamics, Janssen, Medtronic, Novo Nordisk, Rhythm, USGI Medical, Zafgen

Relationship: Research Support
Company: Ethicon

Name: Sriram Machineni, MD
Relationship: Consultant
Company: Ethicon Endosurgery

Course Faculty:

Name: Nadia Ahmad, MD
Relationship: Consultant
Companies: Johnson & Johnson, Medtronic (formerly Covidien)

Relationship: Employee
Company: Ethicon

Name: Paul Copeland, MD, MPhil
Relationship: Consultant
Company: Sanofi

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

ACTIVITY COMMERCIAL SUPPORT

This activity is supported by educational grants from Ethicon, Medtronic, Novo Nordisk, and Rhythm.

COURSE DIRECTORS

Lee M. Kaplan, MD, PhD, is director of the Obesity, Metabolism and Nutrition Institute and founding director of the Weight Center at the Massachusetts General Hospital (MGH), and associate professor of medicine at Harvard Medical School (HMS). His research focuses on the role of the GI tract in the regulation of energy balance and metabolic function, including the mechanism of action of bariatric and metabolic surgery.

Dr. Kaplan is director of the subspecialty fellowship program in Obesity Medicine and Nutrition at MGH, director of the Blackburn Course in Obesity Medicine at HMS, and associate director of the Nutrition Obesity Research Center at Harvard. He currently serves in many leadership roles, including as vice president of the Obesity Society, immediate past chair of the obesity, metabolism and nutrition section of the American Gastroenterological Association (AGA), chair of the bariatric surgery section and chair of the Clinical Committee of The Obesity Society.

Dr. Kaplan is on the editorial boards of several scientific journals and the scientific advisory boards of several NIH-sponsored research consortia, as well as pharmaceutical, medical device, and biotechnology companies. He has been a member of the Advisory Council of the National Institute for Diabetes and Digestive and Kidney Diseases of the NIH since October 2014.

Dr. Kaplan graduated from Harvard University and received his MD and PhD in molecular biology from the Albert Einstein College of Medicine. He completed an internship and residency in internal medicine and a fellowship in gastroenterology at Massachusetts General Hospital and Harvard Medical School and a fellowship in genetics at Brigham and Women’s Hospital. He is the author of more than 200 medical and scientific papers.

Dr. Kaplan can be reached at Kaplan.Lee@mgh.harvard.edu.

Sriram Machineni, MD, is the director of the Medical Weight Clinic at the University of North Carolina (UNC) Medical Center and an assistant professor of medicine at the University of North Carolina School of Medicine. Prior to joining UNC, Dr. Machineni was an obesity medicine specialist at the Massachusetts General Hospital (MGH) Weight Center. He served as faculty for the MGH Obesity Metabolism and Nutrition Institute (OMNI) was a co-director of the Blackburn Course in Obesity Medicine: Treating Obesity 2017 and the Obesity Medicine Board Review Course.

Dr. Machineni received his medical degree from the All India Institute of Medical Sciences and completed his residency in internal medicine from the State University of New York at Buffalo. He served as the chief medical resident at the Buffalo General Hospital and stayed on to serve in the roles of director of the Primary Medicine and the Weight Management clinics. He trained in clinical research at the New York Obesity and Nutrition Research center in New York City, and moved to Boston to complete a clinical and research fellowship in obesity medicine at MGH.

Dr. Machineni specializes in treatment of obesity and has expertise in obesity pharmacotherapy. His research focus is the study of mechanisms of energy regulation in response to nutrients and obesity surgery to help develop new therapies for obesity. His teaching interests include the development of tools and approaches for the treatment of obesity in the primary care setting, and he is spearheading programs to educate primary care practitioners on the use of a novel stepwise approach to the management of obesity.

Dr. Machineni is fellowship-trained in obesity medicine from MGH, board certified in internal medicine and is a 2012 diplomate of the American Board of Obesity Medicine.

Dr. Machineni can be reached at smachineni@med.unc.edu.

FREQUENTLY ASKED QUESTIONS

How long will this course take?

This course should take approximately about 7.75 hours to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments on Dec. 5, 2018, one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.

Enroll